<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s1{background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s0{background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="1860626763C0" style="width:807px;" class="column-headers-background">A</th><th id="1860626763C1" style="width:100px;" class="column-headers-background">B</th></tr></thead><tbody><tr style="height: 20px"><th id="1860626763R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0" dir="ltr">Pregnancy &amp; Breast Ca</td><td></td></tr><tr style="height: 20px"><th id="1860626763R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td></td><td></td></tr><tr style="height: 20px"><th id="1860626763R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td class="s1" dir="ltr">Women presenting with a breast lump during pregnancy should be referred to a breast specialist team and any imaging or further tests should be conducted in conjunction with the multidisciplinary team.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td class="s1" dir="ltr">Bone scanning and pelvic X-ray computed tomography are not recommended because of the possible effect of irradiation on the fetus.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s1" dir="ltr">The decision to continue the pregnancy should be based on careful discussion of the cancer prognosis, treatment and future fertility with the woman and her partner and multidisciplinary team.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td class="s1" dir="ltr">The multidisciplinary team review outcome should be forwarded to the obstetric team and family doctor.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td class="s1" dir="ltr">Tamoxifen and trastuzumab are contraindicated in pregnancy and should not be used.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td class="s1" dir="ltr">The birth of the baby should be timed after discussion with the woman and the multidisciplinary team</td><td></td></tr><tr style="height: 20px"><th id="1860626763R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td class="s1" dir="ltr">Women should not breastfeed when taking trastuzumab (HerceptinÂ®, Roche) or tamoxifen, as it is unknown whether these drugs are transmitted in breast milk.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td class="s1" dir="ltr">Non-hormonal contraceptive methods are recommended.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td class="s1" dir="ltr">Women planning a pregnancy after treatment for breast cancer should consult their clinical oncologist, breast surgeon and obstetrician.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td class="s1" dir="ltr">Women can be reassured that long-term survival after breast cancer is not adversely affected by pregnancy.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td class="s1" dir="ltr">Advice on postponement of pregnancy should be individualised and based on treatment needs and prognosis over time. Most women should wait at least 2 years after treatment, which is when the risk of cancer recurrence is highest.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td class="s1" dir="ltr">Women can be reassured concerning the risk of malformation in children conceived after treatment for breast cancer.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td class="s1" dir="ltr">Pregnancy following breast cancer should be jointly supervised by the obstetrician, oncologist and breast surgeon. Echocardiography should be performed during pregnancy in women at risk to detect cardiomyopathy through resting left ventricular ejection fraction or echocardiographic fractional shortening.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td class="s1" dir="ltr">Women can be reassured that they can breastfeed from the unaffected breast.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td class="s1" dir="ltr">The effect of treatment on fertility should be discussed with all women of reproductive age diagnosed with breast cancer, and written information should be provided. Referral to a fertility specialist should be available. Specialist counselling should be available.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td class="s1" dir="ltr">There are insufficient level 1 data to support the routine use of GnRH analogues for ovarian protection in estrogen receptor positive breast cancer.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td class="s1" dir="ltr">Ovarian stimulation for egg or embryo freezing requires careful discussion in light of unknown long-term risks. Modified stimulation regimes should be considered for women with estrogen-sensitive breast cancer.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td class="s1" dir="ltr">There are insufficient data to support ovarian tissue storage for fertility preservation in women with breast cancer; this should be offered only in the context of a research trial.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td class="s1" dir="ltr">Every breast oncology service should have a designated pathway for prompt referral to a fertility specialist able to offer assisted conception; service provision should not be dependent on local in vitro fertilistion funding arrangements.</td><td></td></tr><tr style="height: 20px"><th id="1860626763R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td></td><td></td></tr><tr style="height: 20px"><th id="1860626763R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td class="s0" dir="ltr">Source</td><td class="s0" dir="ltr">GTG 12</td></tr></tbody></table></div>